skip to Main Content
  • This page as PDF

Prepare for New Diagnostic Reimbursement Coding Changes


Seeking reimbursement for molecular diagnostic testing has always been complicated – even more so due to recent coding changes that eliminated the old “stacking codes” with little time for industry to adjust. Join us for an interactive webinar as we outline the current payment shake-up and identify ways to adapt your strategy in the face of these new coding and payment reforms.

During this webinar, you will:

Learn about current regulatory paradigms for molecular and companion diagnostics and the distinctions between lab-developed and FDA-approved tests
Understand the new molecular pathology Current Procedural Terminology (CPT®) codes and how they differ from the old “stacking codes”
Learn how your payment will be impacted by the new molecular diagnostic coding system


Dan Mendelson , Founder

Dan Mendelson is Founder and former CEO of Avalere Health, a vibrant community of innovative thinkers dedicated to solving the challenges of the healthcare system.

Back To Top